It seems that daclizumab may be coming to a neurologist near you. Beware!
US regulators OK once-monthly MS shot.
http://www.pharmatimes.com/news/us_regu ... ot_1032347
US patients with multiple sclerosis could soon gain access to a new treatment option after the US Food and Drug Administration approved Biogen and AbbVie's once-monthly, self-administered subcutaneous injection Zinbryta.
.............................................................................................
The boxed warning informs prescribers that the drug can cause severe liver injury, including life-threatening and fatal events, and also highlights other important risks of treatment including immune conditions, such as inflammation of the colon, skin reactions, and enlargement of lymph nodes.
Additional highlighted warnings include hypersensitivity reactions (anaphylaxis or angioedema), increased risk of infections, and symptoms of depression and/or suicidal ideation.
US regulators OK once-monthly MS shot
Re: US regulators OK once-monthly MS shot
"the drug can cause severe liver injury, including life-threatening and fatal events"
How do drugs like this ever get approved in the first place?
How do drugs like this ever get approved in the first place?
Re: US regulators OK once-monthly MS shot
It seems like "first do no harm" has fallen to the double edged sword of money and greed.ElliotB wrote: "the drug can cause severe liver injury, including life-threatening and fatal events"
How do drugs like this ever get approved in the first place?